Survival of High Grade Glioma Patients Treated by Three Radiation Schedules with Chemotherapy: A Retrospective Comparative Study (original) (raw)
Hypofractionated radiotherapy results of patients with malign glioma aged 60 and over
Muzaffer Bedri Altundağ
Journal of Health Sciences and Medicine, 2021
View PDFchevron_right
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83‐02
Laurie Gaspar
Cancer, 1996
View PDFchevron_right
Phase I Study of Hypofractionated Intensity Modulated Radiation Therapy with Concurrent and Adjuvant Temozolomide in Patients with Glioblastoma Multiforme
Colin Field
International Journal of Radiation Oncology*Biology*Physics, 2010
View PDFchevron_right
Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424
Jean-paul Bahary, Chen Hu
International Journal of Radiation Oncology*Biology*Physics, 2015
View PDFchevron_right
Assessment of compliance to treatment and efficacy of a resource-sparing hypofractionated radiotherapy regimen in patients with poor-prognosis high-grade gliomas
Tejpal Gupta
Journal of Cancer Research and Therapeutics, 2010
View PDFchevron_right
A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844
Maria grazia Fabrini
International Journal of Radiation Oncology*Biology*Physics, 1996
View PDFchevron_right
Radiosurgery for high-grade glioma
Isabelle Germano
Surgical Neurology International, 2012
View PDFchevron_right
Short Course versus Standard Course of Radiotherapy in Glioblastoma Multiforme
Amr Sakr
Journal of Nuclear Medicine & Radiation Therapy, 2018
View PDFchevron_right
Radiation Therapy Dose Escalation for Glioblastoma Multiforme in the Era of Temozolomide
Michael Chicoine
International Journal of Radiation Oncology*Biology*Physics, 2014
View PDFchevron_right
Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial
Dayanand Sharma
Journal of Neuro-oncology, 2023
View PDFchevron_right
Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience
Jeffrey Cao
Journal of Neuro-Oncology, 2012
View PDFchevron_right
Accelerated Hypofractionated Intensity-Modulated Radiotherapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma Multiforme: A Safety and Efficacy Analysis
Thierry Muanza, Lily Shakibnia
International Journal of Radiation Oncology*Biology*Physics, 2009
View PDFchevron_right
High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy
Maurizio Valeriani, Vincenzo Tombolini
Anticancer research
View PDFchevron_right
Hypofractionated accelerated radiotherapy (HART) with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM)
Dayanand Sharma
Journal of Clinical Oncology, 2018
View PDFchevron_right
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study
Alba Fiorentino
Journal of Neuro-Oncology, 2010
View PDFchevron_right
Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?
Peter Colley
The British Journal of Radiology, 2012
View PDFchevron_right
Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma
Giuseppe Minniti
Tumori, 2010
View PDFchevron_right
Response to GH treatment after radiation therapy depends on location of irradiation
Adda Grimberg
Yearbook of pediatric endocrinology, 2021
View PDFchevron_right
Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis
Matteo Luigi Simonelli
Tumori, 2018
View PDFchevron_right
Phase I Trial of Hypofractionated Intensity-Modulated Radiotherapy With Temozolomide Chemotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Laurie Gaspar
International Journal of Radiation Oncology*Biology*Physics, 2011
View PDFchevron_right
Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma
S. Elyan
British Journal of Cancer, 1995
View PDFchevron_right
A Systematic Overview of Radiation Therapy Effects in Brain Tumours
Peter Wersäll
Acta Oncologica, 2003
View PDFchevron_right
The results of postoperative irradiation in malignant glioma patients
Agnieszka Florek
Reports of Practical Oncology & Radiotherapy, 2005
View PDFchevron_right
Radiotherapy with concurrent or sequential temozolomide in elderly patients with glioblastoma multiforme
Chandrababu Rejeeth, Maher Sughayer, Ahmed Salem
Journal of Medical Imaging and Radiation Oncology, 2012
View PDFchevron_right
A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG)
Dante Amelio
Cancers, 2011
View PDFchevron_right
Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiforme
Silky Chotai
Journal of Clinical Neuroscience, 2014
View PDFchevron_right
Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status
Kathryn Beal
Journal of Neuro-Oncology, 2012
View PDFchevron_right
Survival after radiation therapy for high-grade glioma
Joana Spaggiari Marra
Reports of Practical Oncology & Radiotherapy, 2019
View PDFchevron_right
An institutional evaluation of radiotherapy with concurrent and adjuvant temozolomide exclusively in grade III gliomas
Venkata pradeep babu koyyala
International Journal of Research in Medical Sciences, 2021
View PDFchevron_right
The results of hypofractionated radiotherapy in 31 patients with high-grade gliomas
Bekir Bakkal
Medical Oncology, 2007
View PDFchevron_right
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
Matteo Simonelli
Oncotarget, 2017
View PDFchevron_right